Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer
Molecular Oncology · 06.08.2026
DOI: 10.1002/1878-0261.70315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 06.08.2026. Verfasst von Gerben Lassche und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. C.J. Vaillant Fund, Radboud Oncology Fund.
Abstract (Originalsprache)
Genetic tumour heterogeneity, driven by clonal evolution, contributes to therapy resistance in many cancers. Most salivary gland cancers, including adenoid cystic carcinoma (AdCC) and myoepithelial carcinoma (MECA), lack effective systemic treatments, highlighting the need to characterise their evolutionary profiles. In this autopsy study, we reconstructed genetic heterogeneity and clonal evolution in two patients with metastatic AdCC and one patient with metastatic MECA. Radiology‐guided autopsy was performed between 12 and 56 h after out‐of‐hospital death. One hundred forty‐nine tumour samples were snap‐frozen, of which 17 (4–7 per patient) were selected for whole‐genome sequencing. Phylogenetic reconstruction was performed using CONIPHER. Autopsy revealed multiple metastatic sites not visible on antemortem or postmortem imaging. MYB‐NFIB gene fusions were present across all tumour sites from the two AdCC patients, while a LIFR‐PLAG1 fusion was detected in all samples from the MECA patient. All three cases showed extensive genetic tumour heterogeneity and branched phylogenies, suggestive of parallel evolution. Histologic growth patterns were consistent across metastatic sites. Overall, this study demonstrated marked genetic heterogeneity and branched evolution in these AdCC and MECA patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
- Radboud Technology Center for Bioinformatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Medical Imaging, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Urology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Niels J van Ruitenbeek, Carla M L van Herpen
Förderung
- Dr. C.J. Vaillant Fund
- Radboud Oncology Fund
Zitieren
APA
Lassche, G., van Ruitenbeek, N. J., Adang, C., O'Gorman, L., Lee, P. Y., Klein, W. M., van Engen-van Grunsven, A. C. H., Schalken, J. A., Bervoets, S., Verhaegh, G. W., & van Herpen, C. M. L. (2026). Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.70315
Vancouver
Lassche G, van Ruitenbeek NJ, Adang C, O'Gorman L, Lee PY, Klein WM, et al. Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer. Molecular Oncology. 2026. doi:10.1002/1878-0261.70315
BibTeX
@article{Lassche2026,
author = {Lassche, Gerben and van Ruitenbeek, Niels J and Adang, Charlotte and O'Gorman, Luke and Lee, Pui Yuen and Klein, Willemijn M and van Engen-van Grunsven, Adriana C H and Schalken, Jack A and Bervoets, Sander and Verhaegh, Gerald W and van Herpen, Carla M L},
title = {Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer},
journal = {Molecular Oncology},
year = {2026},
doi = {10.1002/1878-0261.70315}
}
EUVIMED